Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study

Clinical trial NCT07583511 · RECRUITING

Trial details

NCT number: NCT07583511
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Small-cell Lung Cancer

Start date: 2024-02-01
Primary completion: 2027-05-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.